The Impact of “Close Margins” in HPV‐Associated Oropharyngeal Squamous Cell Carcinoma Treated With TORS
Otolaryngology–Head and Neck Surgery · 2025
DOI: 10.1002/ohn.1127 ↗At a glance
Multizentrische Studie in Otolaryngology–Head and Neck Surgery, 2025. Written by Gabriela A Calcano and 10 co-authors. Institution: Department of Otolaryngology-Head and Neck Surgery, Mayo Clinic, Rochester, Minnesota, USA. Major MEDLINE topics: Oropharyngeal Neoplasms, Margins of Excision, Papillomavirus Infections, Carcinoma, Squamous Cell. Cited 5 times so far (Crossref); 26 references.
Abstract (original language)
Objective
Margin distance is a significant prognosticator in oral cavity cancer but its role in HPV‐related oropharyngeal squamous cell carcinoma [HPV(+)OPSCC] remains unclear. Here, we investigate the impact of margin distance on locoregional recurrence in HPV(+)OPSCC. Study Design This is a retrospective cohort study of surgically treated HPV(+)OPSCC patients. Patients received either standard of care (at least 60 Gy with or without cisplatin) or de‐escalated adjuvant therapy (30‐36 Gy with concurrent docetaxel). Margin distance was measured in mm from the primary specimen or in combination with separately submitted margins. Kaplan‐Meier survival analysis with univariate and multivariable Cox regressions were conducted to determine the impact of margin distance on risk of local and locoregional recurrence.
Setting
Setting for this is 3 tertiary centers between January 2010 and February 2024.
Results
Among 1102 included patients, 33 (3.0%) had positive final margins. 374 patients had adequate margin distance data available. Margin distance was >3 mm in 73.4%, 1 to 3 mm in 24.5%, and .05).
Conclusion
Positive final margins after TORS without adjuvant radiotherapy for HPV(+)OPSCC carries a high risk of local recurrence. Margin distance does not appear to significantly impact risk of local or locoregional recurrence, even after de‐escalated adjuvant radiotherapy.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Otolaryngology-Head and Neck Surgery, Mayo Clinic, Rochester, Minnesota, USA.
- Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota, USA.
- Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA.
- Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, Arizona, USA.
- Department of Pathology, Mayo Clinic, Rochester, Minnesota, USA.
ORCID profiles: Gabriela A Calcano, Kathryn M Van Abel, Linda X Yin
Cite
APA
Calcano, G. A., Rourk, K. S., Routman, D. M., O'Byrne, J. J., Chintakuntlawar, A. V., Garcia, J. J., Price, D. L., Tasche, K. K., Moore, E. J., Van Abel, K. M., & Yin, L. X. (2025). The Impact of “Close Margins” in HPV‐Associated Oropharyngeal Squamous Cell Carcinoma Treated With TORS. Otolaryngology–Head and Neck Surgery. https://doi.org/10.1002/ohn.1127
Vancouver
Calcano GA, Rourk KS, Routman DM, O'Byrne JJ, Chintakuntlawar AV, Garcia JJ, et al. The Impact of “Close Margins” in HPV‐Associated Oropharyngeal Squamous Cell Carcinoma Treated With TORS. Otolaryngology–Head and Neck Surgery. 2025. doi:10.1002/ohn.1127
BibTeX
@article{Calcano2025,
author = {Calcano, Gabriela A and Rourk, Katelyn S and Routman, David M and O'Byrne, Jamie J and Chintakuntlawar, Ashish V and Garcia, Joaquin J and Price, Daniel L and Tasche, Kendall K and Moore, Eric J and Van Abel, Kathryn M and Yin, Linda X},
title = {The Impact of “Close Margins” in HPV‐Associated Oropharyngeal Squamous Cell Carcinoma Treated With TORS},
journal = {Otolaryngology–Head and Neck Surgery},
year = {2025},
doi = {10.1002/ohn.1127}
}
EUVIMED